| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | SCF complex assembly | 2.52e-05 | 2 | 104 | 2 | GO:0010265 | |
| GeneOntologyBiologicalProcess | lipoate metabolic process | 2.52e-05 | 2 | 104 | 2 | GO:0009106 | |
| Domain | Put_53exo | 3.13e-05 | 2 | 105 | 2 | IPR004859 | |
| Domain | TATA-bd_TIP120 | 3.13e-05 | 2 | 105 | 2 | IPR013932 | |
| Domain | 5_3_exoribonuclease | 3.13e-05 | 2 | 105 | 2 | IPR027073 | |
| Domain | TIP120 | 3.13e-05 | 2 | 105 | 2 | PF08623 | |
| Domain | XRN_N | 3.13e-05 | 2 | 105 | 2 | PF03159 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 1.45e-05 | 203 | 77 | 8 | M5485 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 3.20e-05 | 165 | 77 | 7 | MM15026 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ZHX3 GAPVD1 CAND1 AHCTF1 HLCS RRBP1 BCOR MPRIP CLMN SUMO1 TLN1 XRN1 DLD PIH1D1 FKBP4 VCL TP53BP1 AHNAK2 | 5.53e-10 | 934 | 107 | 18 | 33916271 |
| Pubmed | CAND2 DHX58 BCOR TULP4 TGFBRAP1 BUD31 FGF12 HERC2 EXOC7 CSPP1 BAHCC1 | 2.18e-08 | 371 | 107 | 11 | 15747579 | |
| Pubmed | XRN2 CAND1 NRCAM ARFGEF2 HLCS CRTAC1 RRBP1 SLC4A3 ZEB2 RYR3 MPRIP TXNDC15 ZNF532 APPL1 TMEM131 KIF5A HERC2 EXOC7 | 7.55e-08 | 1285 | 107 | 18 | 35914814 | |
| Pubmed | GAPVD1 XRN2 EPPK1 AHCTF1 DICER1 TLN1 XRN1 DLD HERC2 FKBP4 VCL TP53BP1 | 8.49e-07 | 653 | 107 | 12 | 22586326 | |
| Pubmed | 1.22e-06 | 110 | 107 | 6 | 27889896 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 1.73e-06 | 184 | 107 | 7 | 32908313 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ZHX3 GAPVD1 XRN2 ARFGEF2 REST RRBP1 BCOR KANSL3 PWWP2B IQSEC1 APPL1 TP53BP1 | 4.87e-06 | 774 | 107 | 12 | 15302935 |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 5.77e-06 | 38 | 107 | 4 | 30786075 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 7.73e-06 | 231 | 107 | 7 | 16452087 | |
| Pubmed | CACNA1E CAND1 NRCAM BCOR ZEB2 MPRIP WDR45 IQSEC1 APPL1 KIF5A HERC2 CEP170B TP53BP1 | 8.52e-06 | 963 | 107 | 13 | 28671696 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 27169142 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 16407302 | ||
| Pubmed | Dystrophin-glycoprotein complex and vinculin-talin-integrin system in human adult cardiac muscle. | 9.38e-06 | 2 | 107 | 2 | 19148538 | |
| Pubmed | Vinculins interaction with talin is essential for mammary epithelial differentiation. | 9.38e-06 | 2 | 107 | 2 | 31804547 | |
| Pubmed | Mutation screening and association analysis of six candidate genes for autism on chromosome 7q. | 9.38e-06 | 2 | 107 | 2 | 15523497 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 24452377 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 15705715 | ||
| Pubmed | Two distinct head-tail interfaces cooperate to suppress activation of vinculin by talin. | 9.38e-06 | 2 | 107 | 2 | 15728584 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 24452080 | ||
| Pubmed | Structural basis for amplifying vinculin activation by talin. | 9.38e-06 | 2 | 107 | 2 | 15070891 | |
| Pubmed | Structural Insight into Binding of the ZZ Domain of HERC2 to Histone H3 and SUMO1. | 9.38e-06 | 2 | 107 | 2 | 32726574 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 25673723 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FUT10 CAND1 PPFIA2 ZBTB8A RRBP1 DNAH14 KANSL3 PWWP2B TULP4 ZNF532 CLMN GALNT11 TGFBRAP1 ZNF839 CEP170B TMEM63A | 1.29e-05 | 1489 | 107 | 16 | 28611215 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | GAPVD1 HLCS STIL TLN1 XRN1 DLD TMEM131 HERC2 PIH1D1 FKBP4 CEP170B VCL | 1.29e-05 | 853 | 107 | 12 | 28718761 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.50e-05 | 256 | 107 | 7 | 33397691 | |
| Pubmed | CDK16 XRN2 EPPK1 CAND1 CHN1 MPRIP ARHGAP22 DLC1 TLN1 DLD APPL1 FKBP4 | 2.60e-05 | 916 | 107 | 12 | 32203420 | |
| Pubmed | 2.72e-05 | 634 | 107 | 10 | 34591612 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 2.73e-05 | 281 | 107 | 7 | 28706196 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 23389036 | ||
| Pubmed | The vinculin binding sites of talin and alpha-actinin are sufficient to activate vinculin. | 2.81e-05 | 3 | 107 | 2 | 16407299 | |
| Pubmed | TIP120B: a novel TIP120-family protein that is expressed specifically in muscle tissues. | 2.81e-05 | 3 | 107 | 2 | 10441524 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 17591693 | ||
| Pubmed | Mechanotransduction in talin through the interaction of the R8 domain with DLC1. | 2.81e-05 | 3 | 107 | 2 | 30028837 | |
| Pubmed | Interaction of the developmental regulator SALL1 with UBE2I and SUMO-1. | 2.81e-05 | 3 | 107 | 2 | 12200128 | |
| Pubmed | Central region of talin has a unique fold that binds vinculin and actin. | 2.81e-05 | 3 | 107 | 2 | 20610383 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 19952892 | ||
| Pubmed | Dual role of vinculin in barrier-disruptive and barrier-enhancing endothelial cell responses. | 2.81e-05 | 3 | 107 | 2 | 26923917 | |
| Pubmed | TBP-interacting protein 120B, which is induced in relation to myogenesis, binds to NOT3. | 2.81e-05 | 3 | 107 | 2 | 12207886 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 31659275 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 32238906 | ||
| Pubmed | Talin and vinculin are downregulated in atherosclerotic plaque; Tampere Vascular Study. | 2.81e-05 | 3 | 107 | 2 | 27816808 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 32561773 | ||
| Pubmed | Cytoskeletal proteins talin and vinculin in integrin-mediated adhesion. | 2.81e-05 | 3 | 107 | 2 | 15494027 | |
| Pubmed | Vinculin controls talin engagement with the actomyosin machinery. | 2.81e-05 | 3 | 107 | 2 | 26634421 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 21763488 | ||
| Pubmed | Vinculin controls focal adhesion formation by direct interactions with talin and actin. | 2.81e-05 | 3 | 107 | 2 | 18056416 | |
| Pubmed | CAND1 NRCAM PPFIA2 ARFGEF2 RRBP1 MPRIP PTPRZ1 CLMN TLN1 XRN1 IQSEC1 DLD ATP2B3 CEP170B VCL | 3.29e-05 | 1431 | 107 | 15 | 37142655 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPPK1 ARFGEF2 MPRIP KANSL3 PWWP2B TULP4 TLN1 TMCC2 HERC2 ZNF839 CEP170B AHNAK2 BAHCC1 | 3.59e-05 | 1105 | 107 | 13 | 35748872 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.96e-05 | 202 | 107 | 6 | 33005030 | |
| Pubmed | CAND2 AHCTF1 RRBP1 DICER1 MPRIP CLMN TLN1 DLD TMEM131 HERC2 PIH1D1 CSPP1 FKBP4 VCL TP53BP1 | 5.09e-05 | 1487 | 107 | 15 | 33957083 | |
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 10320340 | ||
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 16000373 | ||
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 20308429 | ||
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 10051563 | ||
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 23679094 | ||
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 9054445 | ||
| Pubmed | Vinculin regulates assembly of talin: β3 integrin complexes. | 5.60e-05 | 4 | 107 | 2 | 24446374 | |
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 32316405 | ||
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 23741051 | ||
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 15988023 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CDK16 GAPVD1 AHCTF1 RRBP1 MPRIP KANSL3 RMI1 SUMO1 TLN1 HERC2 CEP170B VCL TP53BP1 | 5.63e-05 | 1155 | 107 | 13 | 20360068 |
| Pubmed | 5.74e-05 | 216 | 107 | 6 | 31519766 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | CAND1 PPFIA2 AHCTF1 NEB SLC5A1 CLIC5 ARSF TLN1 APPL1 FKBP4 VCL TMEM63A | 7.03e-05 | 1016 | 107 | 12 | 19056867 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CDK16 GAPVD1 STIL MPRIP DLC1 CLMN XRN1 IQSEC1 CSPP1 CEP170B AHNAK2 | 7.18e-05 | 861 | 107 | 11 | 36931259 |
| Pubmed | 7.19e-05 | 225 | 107 | 6 | 12168954 | ||
| Pubmed | Genome-wide association of lipid-lowering response to statins in combined study populations. | 7.42e-05 | 72 | 107 | 4 | 20339536 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 8.76e-05 | 588 | 107 | 9 | 38580884 | |
| Pubmed | Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by P210BCR/ABL. | 9.32e-05 | 5 | 107 | 2 | 7534286 | |
| Pubmed | 1.07e-04 | 151 | 107 | 5 | 17043677 | ||
| Pubmed | 1.14e-04 | 153 | 107 | 5 | 10718198 | ||
| Pubmed | ZHX3 XRN2 BCOR ZEB2 MPRIP KANSL3 SALL1 SUMO1 XRN1 DLD HERC2 FKBP4 VCL TP53BP1 | 1.26e-04 | 1429 | 107 | 14 | 35140242 | |
| Pubmed | 1.40e-04 | 6 | 107 | 2 | 25369991 | ||
| Pubmed | Mice carrying a complete deletion of the talin2 coding sequence are viable and fertile. | 1.40e-04 | 6 | 107 | 2 | 22925892 | |
| Pubmed | MicroRNA targeting of CoREST controls polarization of migrating cortical neurons. | 1.40e-04 | 6 | 107 | 2 | 24794437 | |
| Pubmed | 1.49e-04 | 494 | 107 | 8 | 26831064 | ||
| Pubmed | ZHX3 XRN2 CAND1 BCOR ZEB2 CCDC7 KANSL3 SUMO1 TLN1 BUD31 FKBP4 TP53BP1 | 1.52e-04 | 1103 | 107 | 12 | 34189442 | |
| Pubmed | 1.56e-04 | 497 | 107 | 8 | 23414517 | ||
| Pubmed | Web-based, participant-driven studies yield novel genetic associations for common traits. | 1.58e-04 | 34 | 107 | 3 | 20585627 | |
| Pubmed | 1.62e-04 | 638 | 107 | 9 | 31182584 | ||
| Pubmed | 1.69e-04 | 263 | 107 | 6 | 34702444 | ||
| Pubmed | AHCTF1 HLCS BCOR DICER1 PWWP2B PCDH19 XRN1 IQSEC1 ABHD8 TAF11 CEP170B BAHCC1 | 1.69e-04 | 1116 | 107 | 12 | 31753913 | |
| Pubmed | 1.92e-04 | 92 | 107 | 4 | 20368287 | ||
| Pubmed | 1.95e-04 | 7 | 107 | 2 | 21169563 | ||
| Pubmed | 1.95e-04 | 7 | 107 | 2 | 23266827 | ||
| Pubmed | 1.95e-04 | 7 | 107 | 2 | 22956851 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 1.98e-04 | 807 | 107 | 10 | 30575818 | |
| Pubmed | 2.37e-04 | 529 | 107 | 8 | 14621295 | ||
| Pubmed | 2.42e-04 | 399 | 107 | 7 | 35987950 | ||
| Pubmed | 2.50e-04 | 283 | 107 | 6 | 21903422 | ||
| Pubmed | 2.59e-04 | 8 | 107 | 2 | 22017400 | ||
| Pubmed | A HECT domain E3 enzyme assembles novel polyubiquitin chains. | 2.59e-04 | 8 | 107 | 2 | 11278995 | |
| Pubmed | beta-Dystroglycan modulates the interplay between actin and microtubules in human-adhered platelets. | 2.59e-04 | 8 | 107 | 2 | 18341635 | |
| Pubmed | A protein interaction network for pluripotency of embryonic stem cells. | 2.77e-04 | 41 | 107 | 3 | 17093407 | |
| Pubmed | 2.98e-04 | 42 | 107 | 3 | 19449303 | ||
| Pubmed | 3.04e-04 | 549 | 107 | 8 | 38280479 | ||
| Pubmed | 3.05e-04 | 189 | 107 | 5 | 31594818 | ||
| Pubmed | 3.19e-04 | 105 | 107 | 4 | 24667918 | ||
| Pubmed | 3.33e-04 | 9 | 107 | 2 | 21423180 | ||
| Pubmed | Pellino1 specifically binds to phospho-Thr18 of p53 and is recruited to sites of DNA damage. | 3.33e-04 | 9 | 107 | 2 | 30987826 | |
| Pubmed | Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks. | 3.33e-04 | 9 | 107 | 2 | 20016603 | |
| Interaction | NAA40 interactions | ZHX3 GAPVD1 CAND1 AHCTF1 HLCS RRBP1 BCOR MPRIP CLMN SUMO1 TLN1 XRN1 DLD PIH1D1 FKBP4 VCL TP53BP1 AHNAK2 | 2.81e-06 | 978 | 105 | 18 | int:NAA40 |
| Interaction | CARS1 interactions | 3.13e-06 | 120 | 105 | 7 | int:CARS1 | |
| Interaction | PHLPP1 interactions | 9.54e-06 | 333 | 105 | 10 | int:PHLPP1 | |
| Cytoband | 3p25.2 | 2.92e-04 | 11 | 107 | 2 | 3p25.2 | |
| Cytoband | 14q32.13 | 7.15e-04 | 17 | 107 | 2 | 14q32.13 | |
| Cytoband | 1q42.12 | 8.04e-04 | 18 | 107 | 2 | 1q42.12 | |
| Cytoband | Xp22.3 | 1.32e-03 | 23 | 107 | 2 | Xp22.3 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 6.44e-04 | 11 | 63 | 2 | 1168 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 7.03e-04 | 50 | 63 | 3 | 721 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.22e-03 | 15 | 63 | 2 | 529 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | CAND2 PYROXD1 CARS1 ARFGEF2 REST RRBP1 SLC4A3 DICER1 RYR3 MPRIP SUMO1 INTS15 BUD31 IQSEC1 APPL1 TMEM131 VCL | 8.44e-06 | 1215 | 107 | 17 | M41122 |
| Coexpression | GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_UP | 1.80e-05 | 199 | 107 | 7 | M5769 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | ZHX3 BNC2 NRCAM SLC10A4 NAP1L5 ARFGEF2 RYR3 SALL1 DLC1 APPL1 MYOCD KIF5A HERC2 CSPP1 | 5.04e-05 | 818 | 105 | 14 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_top-relative-expression-ranked_500 | NRCAM PPFIA2 SLC10A4 NAP1L5 CRTAC1 CHN1 STK32A PTPRZ1 ABHD8 KIF5A | 6.58e-05 | 440 | 105 | 10 | gudmap_dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_500 |
| CoexpressionAtlas | dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.58e-05 | 202 | 105 | 7 | gudmap_dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k3_1000 | |
| ToppCell | Control-Mast_cells|Control / group, cell type (main and fine annotations) | 7.97e-09 | 169 | 107 | 8 | fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb | |
| ToppCell | Control-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations) | 8.35e-09 | 170 | 107 | 8 | c80f6d29096c372da95a8407f402349ff1bb7018 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.50e-07 | 165 | 107 | 7 | 37615622c736e43260c38016e7c9e565ac97a3e8 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.50e-07 | 165 | 107 | 7 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| ToppCell | nucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.50e-07 | 165 | 107 | 7 | f3df74b5763130c71c0a482a3a23f6b22acc2892 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.20e-07 | 192 | 107 | 7 | efbd52b3d2b6d3fb9ed6bc3f36aca9f4f1fcbc49 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.00e-07 | 197 | 107 | 7 | bed8a9b73af5caee51b1232b31c24a59353658df | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.00e-07 | 197 | 107 | 7 | b7d5073d44aa1e2cb83ea8d8104c5ed662665755 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.53e-07 | 200 | 107 | 7 | 85c0f038bcfb42669dca2b80273b0f8a1421405e | |
| ToppCell | RV-16._Neuronal|World / Chamber and Cluster_Paper | 1.64e-06 | 149 | 107 | 6 | 3a2f8c4173dcf9e3f8d3b8ffddbc597098adf7a9 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.77e-06 | 151 | 107 | 6 | bbf735c6433c3fc2feedb24ed6f48c51d545fb60 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-06 | 160 | 107 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-06 | 160 | 107 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | COVID-19-lung-MAST|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.29e-06 | 176 | 107 | 6 | 473c45a381ca109207d66ed1635668b391ea0e1f | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.20e-06 | 182 | 107 | 6 | 04ccfa951eaa31fed6d140edb6c702d49363c5fa | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.36e-06 | 183 | 107 | 6 | af8d86f15a549064530d94bd47081daf59d58ecd | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.53e-06 | 184 | 107 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.53e-06 | 184 | 107 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.53e-06 | 184 | 107 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.45e-06 | 189 | 107 | 6 | f01158bb15df3117fae1271bf8cf8c2501422671 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.65e-06 | 190 | 107 | 6 | ed100e271aac82806f59e0c613ccda63f59100c1 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.91e-06 | 200 | 107 | 6 | 9156f8fd61a833891d2f7b7fadd693b81b1e2d5a | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.91e-06 | 200 | 107 | 6 | 566fe2e78e6f35399ec6aad5964f6d4d8ade82c6 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.91e-06 | 200 | 107 | 6 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | PBMC-Mild-cDC_2|Mild / Compartment, Disease Groups and Clusters | 1.88e-05 | 135 | 107 | 5 | cb9d834f8301cf53f20e09c3f4cb6a148690196a | |
| ToppCell | Severe-Myeloid-Mast-|Severe / Condition, Lineage, Cell class and cell subclass | 2.65e-05 | 145 | 107 | 5 | ce307d45425a5191882078f049f85477eec40b69 | |
| ToppCell | Severe-Myeloid-Mast|Severe / Condition, Lineage, Cell class and cell subclass | 2.65e-05 | 145 | 107 | 5 | e0bfd2ffdbd6c197ef0a04e983396ebd87ef7127 | |
| ToppCell | RV-16._Neuronal|RV / Chamber and Cluster_Paper | 3.42e-05 | 153 | 107 | 5 | bed8bbf5c5cbfbf46a816066da472c3fdddecb5d | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.53e-05 | 154 | 107 | 5 | 16fdafb5c64d2db321554f87129a962d113f1668 | |
| ToppCell | Adult-Immune-mast_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.64e-05 | 155 | 107 | 5 | 7c9de0591d1bf756b8e268b278bbe10bd5415dcd | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.87e-05 | 157 | 107 | 5 | ec185dbeabb67fd9ca85f71cab88463b60f9b1c1 | |
| ToppCell | Adult-Immune-mast_cell|Adult / Lineage, Cell type, age group and donor | 4.37e-05 | 161 | 107 | 5 | 44f5c0256b3ce264a6c7b62740f32dcd45ee052d | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.20e-05 | 167 | 107 | 5 | 8b223333c0c7a85b5a1af6f2f5b12ee0d94357f6 | |
| ToppCell | Bronchial_Biopsy-Immune-Mast_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.35e-05 | 168 | 107 | 5 | 45ccc0cb42d21f4853190e8e9ed9a54aefefe738 | |
| ToppCell | COVID-19-lung-MAST|lung / Disease (COVID-19 only), tissue and cell type | 5.65e-05 | 170 | 107 | 5 | e90f18e5462381b38e918442b38b1c8105291908 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.65e-05 | 170 | 107 | 5 | 749144a1a869a6bf9acdd227184319083367dc3f | |
| ToppCell | (7)_MNP-(7)_DC_activated|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 5.65e-05 | 170 | 107 | 5 | 4ab495b38a071fa8207331df2ce0d78a2dcd034e | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.65e-05 | 170 | 107 | 5 | 25d60a62e8f99c31ab64fe6a0c07ccca3df1a7ee | |
| ToppCell | Immune-mast_cell|World / Lineage, Cell type, age group and donor | 5.98e-05 | 172 | 107 | 5 | 6e8e0aac5a20dbc789bf8c6916833bb8709a411a | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 6.14e-05 | 173 | 107 | 5 | 7e3897868dd3f6e4974f593c60649a543ffc8693 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.14e-05 | 173 | 107 | 5 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-05 | 174 | 107 | 5 | ff13a5c55d18b951315908f33cb47c7f9cb901bf | |
| ToppCell | Severe-B_intermediate-10|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.03e-05 | 178 | 107 | 5 | b7374a97c51239782bed658381a02cb1b3d9bf66 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-Mast_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.03e-05 | 178 | 107 | 5 | c6704fcd21a9d2fe45679a1d998f04213b3bf224 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.22e-05 | 179 | 107 | 5 | 7c8a2fa1326c73dc9e774df645b572864fd97133 | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 7.22e-05 | 179 | 107 | 5 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.41e-05 | 180 | 107 | 5 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.41e-05 | 180 | 107 | 5 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | critical-Lymphoid-NK|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.41e-05 | 180 | 107 | 5 | 5abf778395392244daaec876f306ed7e4f388686 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.61e-05 | 181 | 107 | 5 | fc51468c74534b60b4e786bd512d0f1c5dc05de7 | |
| ToppCell | NS-critical-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.81e-05 | 182 | 107 | 5 | dd1c59babf7211362452e3e264009d70004d99f6 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-NK|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.81e-05 | 182 | 107 | 5 | fb503f8ecd013f1f2161a5841572b57cfcddb6fa | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.01e-05 | 183 | 107 | 5 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.22e-05 | 184 | 107 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-Tuft-related-Tuft|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.43e-05 | 185 | 107 | 5 | 686ed7550c6acd18e71e0076936ec5b07389adbd | |
| ToppCell | COPD-Myeloid-Mast|COPD / Disease state, Lineage and Cell class | 8.65e-05 | 186 | 107 | 5 | def6f0f284acc2154738574c8c5d3d2a5ef1f208 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.87e-05 | 187 | 107 | 5 | bdcef4f3e093c3646b639a189bbe93d6f4c40f3c | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.87e-05 | 187 | 107 | 5 | 09348f1e8bbbca8dca885461937b9b1dd248b034 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.87e-05 | 187 | 107 | 5 | 0f7a42c55997e34a0d20e492e16b03e91e965335 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.87e-05 | 187 | 107 | 5 | 064730fa72f8637c3db3fc34d2e363d2b9a38f1d | |
| ToppCell | 10x5'-Lung-Mast|Lung / Manually curated celltypes from each tissue | 8.87e-05 | 187 | 107 | 5 | f8ac5ca5cbe9c6f3d8c0fffc20fe08ca1aea43c0 | |
| ToppCell | 10x5'-Lung-Mast-Mast_cells|Lung / Manually curated celltypes from each tissue | 8.87e-05 | 187 | 107 | 5 | da275d2c774b3e6a8ed77f777dd0676ecf2ddd2c | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 9.09e-05 | 188 | 107 | 5 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.09e-05 | 188 | 107 | 5 | 6ee3f8f94ea7bdf652c9575fc65bff08070093a4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.09e-05 | 188 | 107 | 5 | c66fccdfe68760b8c3efca77e3c25966dc9a8a5f | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.09e-05 | 188 | 107 | 5 | bd091503f580dedab40e0996273101285d24b586 | |
| ToppCell | Mesenchymal_cells-Osteoblasts|World / Lineage and Cell class | 9.09e-05 | 188 | 107 | 5 | 89f7f5a51be7e046a63e2413f86c521ae4b6718f | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|368C / Donor, Lineage, Cell class and subclass (all cells) | 9.32e-05 | 189 | 107 | 5 | 610d7cc1fc923dbd67d3b71f94d529a658982f87 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.56e-05 | 190 | 107 | 5 | 7e4d80a3a7f83b6a50f1d0fe82fb6c242c39d5b0 | |
| ToppCell | COPD-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 9.56e-05 | 190 | 107 | 5 | 379dbac19110b76079a7a53209569e060a852acb | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 9.80e-05 | 191 | 107 | 5 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.80e-05 | 191 | 107 | 5 | 06760c3bb40e4f66879a5f5e09c9abfce4ebbba3 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.80e-05 | 191 | 107 | 5 | cadb7a9de16f4bb21606de0e25cddd2d748c7f0b | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 9.95e-05 | 100 | 107 | 4 | 20675fc2ffc5ab63047d38da083b50d470f3db19 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6|Thalamus / BrainAtlas - Mouse McCarroll V32 | 9.95e-05 | 100 | 107 | 4 | 1de3895e16f14ff32b901b18ce14d965afaa7e76 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora|Thalamus / BrainAtlas - Mouse McCarroll V32 | 9.95e-05 | 100 | 107 | 4 | ff1bdb511700a041a90034d1d30dfc25f51d6c82 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.03e-04 | 193 | 107 | 5 | 146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a | |
| ToppCell | critical-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.03e-04 | 193 | 107 | 5 | 6be11fef87af04ee7a3cc223882ccd4077caded9 | |
| ToppCell | (1)_Osterolineage_cells|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.03e-04 | 193 | 107 | 5 | 035eeea9f77c4bf9cd85f07fa791b6c857be76b5 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 193 | 107 | 5 | 1aa3ab528605dc7b2fec46e759c9d1ee93d59b11 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.08e-04 | 195 | 107 | 5 | f1f48e2e57b2282572959b152aad4bee05143f03 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.11e-04 | 196 | 107 | 5 | e08f90f7a923c2846cac859519b8dc7c0ac7cd03 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.11e-04 | 196 | 107 | 5 | f374cb3ec31c6eef2cef9e07547bfd1e380553af | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.11e-04 | 196 | 107 | 5 | 671c380b58d7f634b4fbec38c357d357ea4f3535 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-04 | 197 | 107 | 5 | 9af431323da6d099459b7360af40e5df998cffbd | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.13e-04 | 197 | 107 | 5 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.13e-04 | 197 | 107 | 5 | b8dc192fc98428bbb701cc2ea57fc8ad93397785 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-04 | 198 | 107 | 5 | 882710bd6215e299257dd3df234292db9a2823ba | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-04 | 198 | 107 | 5 | a883e25cb7a78b2ecfb15cef4633bdd02dfafb12 | |
| ToppCell | normal_Lung-Fibroblasts-Smooth_muscle_cells|Fibroblasts / Location, Cell class and cell subclass | 1.19e-04 | 199 | 107 | 5 | d65847ceb68a560798df3f73e6f838e7c3e38a1c | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-KRT5-/KRT17+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.19e-04 | 199 | 107 | 5 | 3b1f56c8b40bb36922a31d2d440a8c468a8aa3f1 | |
| ToppCell | Control-Control-Others-HSPC|Control / Disease, condition lineage and cell class | 1.19e-04 | 199 | 107 | 5 | b71169be0d916b2ed139a3122d78bb154c71edb4 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-04 | 199 | 107 | 5 | 08bdcabc3fce787578a8eb66fc8412b0974fa6cc | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-04 | 200 | 107 | 5 | c3511607692e05f44538a376253673dd18f77908 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.22e-04 | 200 | 107 | 5 | d2fcd3bd7c3223875f027eeb48ff621192a5f242 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-04 | 200 | 107 | 5 | ed093626a9cac7531a2bf02f6e345c5e84b8c060 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-GGH-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.22e-04 | 200 | 107 | 5 | 48303e499251d6754cfa991dc2d96c5563b2123c | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.22e-04 | 200 | 107 | 5 | 786f1ae53e60b5ffbf4bfd393d10b802478148b3 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_epineurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-04 | 200 | 107 | 5 | be46efc899d06c55ee297bee3126f69bcdb2048b | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Mast_cell-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-04 | 200 | 107 | 5 | 1c58860932ed47263a5a537a64f0343201463c21 | |
| Disease | Muckle-Wells Syndrome | 1.22e-04 | 5 | 104 | 2 | C0268390 | |
| Disease | Bilateral Wilms Tumor | 1.45e-04 | 29 | 104 | 3 | C2930471 | |
| Disease | microcephaly (implicated_via_orthology) | 1.96e-04 | 32 | 104 | 3 | DOID:10907 (implicated_via_orthology) | |
| Disease | Nephroblastoma | 2.79e-04 | 36 | 104 | 3 | C0027708 | |
| Disease | body shape measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0801227 | |
| Disease | eosinophil count | BNC2 SMIM29 REST RRBP1 CRLF2 KANSL3 SALL1 CLIC5 CYP26C1 XRN1 HFM1 TMEM131 TP53BP1 BAHCC1 | 7.33e-04 | 1488 | 104 | 14 | EFO_0004842 |
| Disease | Oligodontia | 7.94e-04 | 12 | 104 | 2 | C4082304 | |
| Disease | actinic keratosis | 1.09e-03 | 14 | 104 | 2 | EFO_0002496 | |
| Disease | Hypodontia | 1.09e-03 | 14 | 104 | 2 | C0020608 | |
| Disease | unipolar depression, cognitive function measurement | 1.25e-03 | 15 | 104 | 2 | EFO_0003761, EFO_0008354 | |
| Disease | isocitrate measurement | 1.43e-03 | 16 | 104 | 2 | EFO_0010505 | |
| Disease | Meckel syndrome type 1 | 1.81e-03 | 18 | 104 | 2 | C3714506 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.99e-03 | 276 | 104 | 5 | EFO_0004612, EFO_0020943 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HEITEQPMKAERAGS | 251 | P54793 | |
| LIHSGGDSDSREKPM | 141 | Q9NYP8 | |
| LDDMKSHRLEDNPGV | 266 | P48751 | |
| DQKMREAETEPHEGK | 26 | P41223 | |
| KDRHLEGTMAPDHAA | 421 | Q9P281 | |
| VPIKMEDTTQDAEHG | 101 | Q96BA8 | |
| RSLDEAMPTEGEKDH | 946 | Q15878 | |
| AMPTEGEKDHELRGN | 951 | Q15878 | |
| KRHSTHDEESGENPM | 816 | Q96M83 | |
| HDEESGENPMLKHQD | 821 | Q96M83 | |
| PKLGEESMEGDEHIH | 731 | Q6ZN30 | |
| PVGMEEDSSEKHLDV | 1491 | Q9Y6D5 | |
| SLSLKPSEGMDHGEE | 896 | Q96PN6 | |
| EVPAHEMPTKDAEAG | 241 | Q9Y4F5 | |
| GELDDHLMPVGKETV | 706 | Q9UPY3 | |
| LEMKEREGGHPATKD | 1026 | Q6W2J9 | |
| EGLEEKEGAHMNPEI | 161 | Q9NZA1 | |
| GESDHVRKSADKDPM | 246 | Q16720 | |
| HGPGKDEMTDEELAE | 1071 | Q16720 | |
| HGMHDKFVPVEEDQR | 366 | Q96I13 | |
| DGHEEKMENGQITPD | 676 | Q5JSJ4 | |
| VTKDPGVGMDRDSHL | 271 | Q96N11 | |
| GSEMLHKRDPLDEDE | 386 | Q96EP9 | |
| AEPRGADSEKVMHEV | 1111 | Q8TAB3 | |
| SADIKGEPHGLENME | 96 | Q13127 | |
| DIEKAEHMETNAVGP | 311 | Q6WCQ1 | |
| KAAEDTGGIHMEEAP | 626 | Q9NPP4 | |
| HKEEGSEQAPLMSED | 101 | Q8NI22 | |
| AHADPEIQPMKEDDG | 1206 | Q92823 | |
| SHLAGKGPDSFEMEE | 376 | Q6ZRS4 | |
| KDAPHSEGDMHLLSG | 351 | O95714 | |
| PQTALHGMDHRKLDE | 281 | Q6DN90 | |
| PQIAMDHEHEDGLGL | 2171 | Q2LD37 | |
| FLGSMEVKSDDHPDV | 506 | Q9UKG1 | |
| HSDKEVMGDGESAHD | 1071 | Q14C86 | |
| IKPEQDGMEHVGRDD | 51 | P50747 | |
| MDKKEDRGPEDQESH | 221 | Q9C098 | |
| VEMGPFKHTVDDGLD | 1066 | Q86VP6 | |
| SLVDPDDIMKHIGDD | 1191 | Q1MSJ5 | |
| DDIMKHIGDDGSNSV | 1196 | Q1MSJ5 | |
| DPEEGHLKFSSELGM | 86 | Q8NCW6 | |
| GHKEGLDVMERADPL | 126 | Q9NX47 | |
| DRDDMPDGGAEHIAK | 181 | O43766 | |
| HAELENGMIPTDTKD | 511 | P57789 | |
| EAANRDGPMIVHDEH | 2211 | P23471 | |
| EEPASDKGSEAEAHM | 731 | O94886 | |
| LHKMAGAEQESGPEE | 296 | Q9HC73 | |
| LKIGSEEPHFDGIMD | 826 | Q8IZQ8 | |
| KHGPLAGRDDMLDVE | 346 | Q9UPT5 | |
| HPDDEADEMKSLLGI | 1416 | A2PYH4 | |
| APEIVHEDLKMGSDG | 66 | Q00536 | |
| QDGHTKMEEAPTHLN | 46 | Q6P4F1 | |
| HDHLEMPELSRKFGT | 241 | Q96C10 | |
| ELGHEPSMQELKESA | 276 | Q6V0L0 | |
| VVAGPMLAHKAEDEG | 356 | P09622 | |
| QRPSDHGAAEKHMET | 166 | Q0VDD8 | |
| HGAAEKHMETFIPID | 171 | Q0VDD8 | |
| GDELHPMKAAELGAE | 261 | Q96NU7 | |
| PGHQEDHMVKEPVED | 16 | Q8WWZ3 | |
| KSAEMEPEDSGGIHS | 811 | Q12840 | |
| EGHMGSEPRDQDAEK | 476 | Q9P2N6 | |
| EMEPVAHFGLGKDEA | 486 | Q9NQ79 | |
| LNSPEKEHQEMDEGS | 1281 | Q8WYP5 | |
| ESGEEKQEHLTEMDP | 2511 | Q8NDH2 | |
| SGDHPTDTEMKEEQK | 431 | Q02790 | |
| EMELAGKDPVSHEHE | 16 | Q8IZT9 | |
| MPVLKETHDERDSTG | 161 | P15882 | |
| VEMGPFKHTVDDGLD | 1071 | O75155 | |
| HGRAPEEGDAEVMQL | 66 | Q6NUJ5 | |
| HNGLDREESMEVEAP | 116 | Q9NSC2 | |
| KSLSSEGHHMDLPDV | 841 | Q8IZU8 | |
| STESEHLEGMEPGQK | 236 | O75334 | |
| QMHPDGTIDGTKDEN | 86 | P61328 | |
| FDENGLPTHDMEGKE | 701 | P49589 | |
| MSLGEPHAELDAKGQ | 101 | Q9NWS0 | |
| QQGMSDHDSPDEKER | 111 | O75069 | |
| DHDSPDEKERSPEMH | 116 | O75069 | |
| KEEPSNLSIHVMDGE | 296 | Q9H9A7 | |
| MDDAHESPSDKGGET | 1 | Q15544 | |
| GAKHDDAHAEMPDDA | 166 | Q96NT1 | |
| EMNRVLAHPSDDTKG | 4506 | P58107 | |
| LHEAEQELLSDMGDP | 66 | Q86T20 | |
| PLMEKGHLDHEQVGS | 36 | Q9Y484 | |
| IADNHTPKELGMEEE | 71 | P63165 | |
| DMKPDNILLDEHGHV | 146 | Q8WU08 | |
| RPMGHLSKDVDENDS | 76 | Q96QB1 | |
| EEKGLMAAHEPSGAR | 1331 | Q9NRC6 | |
| PKSLDLDHSMDEAGA | 561 | Q7Z5H3 | |
| SEDADHEGKGSPLKM | 4941 | Q8IVF2 | |
| MDKHEPHQDSGEEAE | 626 | Q96JQ2 | |
| HCTMKRTEDDPEVGG | 441 | Q9NRJ4 | |
| EERNGHEAPMTEIKE | 51 | Q8N8H1 | |
| GKMPIHDHDSGVEDE | 386 | Q15468 | |
| PMESAILHGKLGEHE | 666 | Q8WUH2 | |
| PDMVDPKAAIESGHD | 21 | Q9HCE3 | |
| LEAEQHLMSPSDGDK | 381 | Q96BR9 | |
| MKSHVEDGDIAGAPA | 1261 | Q9P2E9 | |
| EDGGLKVDDHMHTSL | 336 | Q8WU10 | |
| DSSHKRDIEGMGVPE | 331 | Q15413 | |
| KDHFGLEGDEESTML | 406 | Q9Y490 | |
| IEAMDKDFDHHDSPA | 1351 | Q92545 | |
| SDASAPGEGEHKIMD | 196 | Q9H0D6 | |
| EEELLHDPMGQDRAA | 61 | Q96J42 | |
| SHLVIMHEEGEVDGK | 21 | P18206 | |
| MHEEGEVDGKAIPDL | 26 | P18206 | |
| HETPGEGEHKIMEFI | 171 | Q8IZH2 | |
| EAMEIKEHHPEEGSS | 646 | Q12888 | |
| DNLGPKHLSRDMDGE | 456 | A8K0R7 | |
| GDTQESLHIKMEPEE | 41 | O95201 | |
| SKDQDGPSEMQEVHL | 121 | Q08ER8 | |
| NGRDEMDIELHDVSP | 541 | Q7Z2W7 | |
| ERESMPRDGESEKEH | 1126 | O60315 | |
| GLEQHGAPKMTEEEE | 611 | P13866 | |
| PKLSTGEMEVREGDH | 216 | Q9H4I2 | |
| ETEGDHPKGIEMDGK | 276 | P57103 | |
| HHIGAQSIEDDPKIM | 3776 | P20929 |